Top 10 Companies in Ambulatory Cardiac Monitoring Devices Market (2025–2035): Expert View by Spherical Insights

Description

According to a research report published by Spherical Insights & Consulting, The Global Ambulatory Cardiac Monitoring Devices Market Size Is Projected To Grow From USD 8.51 Billion In 2024 To USD 27.91 Billion By 2035, At A CAGR Of 11.4 % During The Forecast Period 2024–2035. The ambulatory cardiac monitoring device market is primarily driven by the increasing prevalence of cardiovascular diseases (CVDs) and arrhythmias, alongside a rapidly aging global population prone to heart conditions.

 

Introduction

The ambulatory cardiac monitoring device market is part of the medical device industry, consisting of the design, manufacture, and sale of medical devices that can be portable or worn to provide continuous heart activity monitoring for a patient while they are doing normal everyday things away from a hospital or clinical setting. In 2026, the Production-Linked Incentive (PLI) Scheme: The Government of India has introduced the PLI scheme for medical devices to promote domestic manufacturing, reduce dependence on imports, and make medical devices more affordable in the country.

 

In the USA, according to the Centers for Disease Control and Prevention, heart disease is the leading cause of death in the United States. Regulatory approvals from the U.S. Food and Drug Administration for AI-based devices are supporting innovation in cardiac monitoring technologies. Key opportunities in the market include growing adoption of AI-based diagnostic technologies, increasing use of telemedicine and remote patient monitoring, and rising demand for wearable and user-friendly cardiac devices.

 

 

Navigate Future Markets with Confidence: Insights from Spherical Insights LLP

The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Ambulatory Cardiac Monitoring Devices Market.

 

Market Segmentation

Global Ambulatory Cardiac Monitoring Devices Market Size, Share, By Device Type (ECG Device, Holter Monitors, Event Monitors, Implantable Loop Recorders, and Mobile Cardiac Telemetry), By End-Use (Ambulatory Care Centers, Hospital & Clinics, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035

 

Ambulatory Cardiac Monitoring Devices Market & Statistics

• The Market Size for Ambulatory Cardiac Monitoring Devices Was Estimated to be worth USD 8.51 Billion in 2024.
• The Market is Going to Expand at a CAGR of 11.4 % between 2025 and 2035.
• The Global Ambulatory Cardiac Monitoring Devices Market Size is anticipated to reach USD 27.91 Billion by 2035.
• North America is expected to generate the largest demand during the forecast period in the Ambulatory Cardiac Monitoring Devices Market.
• Asia Pacific is expected to grow the fastest during the forecast period in the Global Ambulatory Cardiac Monitoring Devices Market.

Regional growth and demand     

Asia Pacific is expected to grow the fastest during the forecast period in the ambulatory cardiac monitoring devices market.  In December 2025, vTitan launched vCardio, an AI-powered wearable cardiac monitor in India designed for continuous ECG monitoring at home and in clinical settings, capable of detecting over 20 cardiac arrhythmias. The Asia Pacific region is growing fastest in the ambulatory cardiac monitoring devices market due to a high prevalence of cardiovascular diseases (CVDs), a rapidly aging population susceptible to arrhythmia, and rising healthcare expenditures.

 

North America is expected to generate the largest demand during the forecast period in the ambulatory cardiac monitoring devices market. In January 2024, Medtronic plc announced U.S. FDA approval for the Reveal LINQ II Insertable Cardiac Monitor (ICM), a wireless device that can record heart rhythm data for up to three years, facilitating earlier arrhythmia detection. North America held the largest share of the ambulatory cardiac monitoring devices market due to a high prevalence of cardiovascular diseases, a large aging population, and early adoption of advanced technology.

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Ambulatory Cardiac Monitoring Devices Market.

 

 

Top 10 trends in the Ambulatory Cardiac Monitoring Devices Market

1. Integration of artificial intelligence (AI) in cardiac monitoring.
2. Increasing adoption of wearable ECG monitoring devices.
3. Growth of remote patient monitoring (RPM).
4. Expansion of telemedicine and telecardiology services.
5. Rising demand for patch-based ECG monitors.
6. Adoption of mobile cardiac telemetry (MCT) systems.
7. Increasing preference for home-based healthcare monitoring.
8. Integration of devices with smartphones and mobile health apps.
9. Growing awareness of cardiovascular disease prevention.
10. Advancements in wireless and IoT-enabled cardiac monitoring technology.

 

• Integration of artificial intelligence (AI) in cardiac monitoring.

AI helps analyze large volumes of ECG data quickly and accurately, enabling early detection of arrhythmias, improving diagnostic efficiency, and supporting healthcare professionals in making faster and more precise clinical decisions.

 

• Increasing adoption of wearable ECG monitoring devices

Wearable ECG devices allow continuous heart monitoring during daily activities, providing real-time data and improving patient convenience, which helps doctors detect irregular heart rhythms that may not appear during short clinical tests.

 

• Growth of remote patient monitoring (RPM).

Remote patient monitoring enables doctors to track patients heart health from home through connected devices, reducing hospital visits, improving chronic disease management, and supporting timely medical intervention when abnormalities occur.

 

• Expansion of telemedicine and telecardiology services.

The rapid growth of telemedicine allows cardiologists to remotely review ECG data and consult with patients, improving access to cardiac care, especially in remote areas, while reducing healthcare costs and hospital workload.

 

• Rising demand for patch-based ECG monitors

Patch-based ECG monitors are lightweight, comfortable, and easy to wear for extended periods, allowing continuous heart rhythm monitoring and improving the detection of intermittent cardiac conditions such as arrhythmias.

 

Empower your strategic planning:

Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the ambulatory cardiac monitoring devices market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.

 

Top 10 Companies Leading the Ambulatory Cardiac Monitoring Devices Market

1. Medtronic
2. Abbott
3. GE Healthcare
4. Philips Healthcare
5. iRhythm Technologies
6. Spacelabs Healthcare
7. Medicalgorithmics
8. Schiller AG
9. BioTelemetry
10. Applied Cardiac Systems

 

• Medtronic

Headquarters: Galway, Ireland

Medtronic was founded in 1949 by Earl Bakken and Palmer Hermundslie. It is one of the worlds largest medical technology companies, developing advanced medical devices and therapies for cardiovascular diseases, diabetes, neurological disorders, and surgical applications. The company is well known for innovations such as pacemakers, implantable cardiac monitors, and remote patient monitoring systems used in ambulatory cardiac care. Medtronic employs over 90,000 people worldwide and generated approximately USD 33-35 billion in annual revenue in 2025. The company operates in more than 150 countries, with extensive manufacturing, research, and development facilities across North America, Europe, Asia-Pacific, and Latin America, serving hospitals, physicians, and healthcare systems globally.

 

• Abbott Laboratories

Headquarters: Abbott Park, Illinois, United States

Abbott Laboratories was founded in 1888 by Wallace Calvin Abbott. It is a global healthcare company that develops medical devices, diagnostics, nutrition products, and branded pharmaceuticals. Abbott is a leading provider of cardiovascular technologies, including implantable cardiac devices, heart monitoring systems, and digital health solutions. The company employs more than 110,000 people worldwide and generates approximately USD 40-42 billion in annual revenue. Abbott operates in over 160 countries, with major manufacturing and research facilities across the United States, Europe, and Asia, serving healthcare providers, hospitals, and patients globally.

 

• GE HealthCare

Headquarters: Chicago, Illinois, United States

GE HealthCare was established as part of the General Electric healthcare division and became an independent public company in 2023. The company provides medical imaging systems, diagnostic technologies, and patient monitoring solutions used in hospitals and healthcare facilities worldwide. Its portfolio includes ECG systems, remote patient monitoring devices, and digital health platforms that support cardiac care and ambulatory monitoring. GE HealthCare employs tens of thousands of people globally and generated around USD 20 billion in revenue in 2024. The company operates major research and manufacturing facilities across North America, Europe, and Asia-Pacific, serving healthcare providers in more than 160 countries.

 

• Philips HealthCare

Headquarters: Amsterdam, Netherlands

Philips Healthcare is a division of Royal Philips, a global health technology company founded in 1891 by Gerard Philips and Frederik Philips. The company develops advanced medical imaging systems, patient monitoring technologies, and digital health solutions used in hospitals and home healthcare environments. Philips Healthcare is a key provider of ECG monitoring systems, wearable cardiac monitoring devices, and telehealth platforms used in ambulatory cardiac monitoring. The company employs around 70,000-75,000 people globally and generates over USD 18-20 billion in annual revenue from health technology solutions. Philips operates major research and development centers in Europe, the United States, China, and India, serving healthcare systems in more than 100 countries worldwide

 

• iRhythm Technologies

Headquarters: San Francisco, California, United States

iRhythm Technologies was founded in 2006 and specializes in digital health solutions for cardiac monitoring and arrhythmia detection. The company is known for its Zio Patch, a wearable cardiac monitoring device that continuously records heart rhythm data for extended periods and uses cloud-based analytics to help physicians detect irregular heart rhythms. iRhythm employs around 1,500-2,000 people globally and generates hundreds of millions of dollars in annual revenue from its cardiac monitoring services and devices. The company operates primarily in North America but is expanding internationally as demand for wearable cardiac monitoring technologies grows.

 

Are you ready to discover more about the ambulatory cardiac monitoring devices market?

The report provides an in-depth analysis of the leading companies operating in the global ambulatory cardiac monitoring devices market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:

 

Company Profiles

• Medtronic
• Business Overview
• Company Snapshot
• Products Overview
• Company Market Share Analysis
• Company Coverage Portfolio
• Financial Analysis
• Recent Developments
• Merger and Acquisitions
• SWOT Analysis
• Abbott
• GE Healthcare
• Philips Healthcare
• iRhythm Technologies
• Spacelabs Healthcare
• Medicalgorithmics
• Schiller AG
• Biotelemetry
• Others

 

Our Insights 

https://www.sphericalinsights.com/reports/middle-east-and-africa-beauty-and-personal-care-market
https://www.sphericalinsights.com/reports/north-america-anemia-supplements-market
https://www.sphericalinsights.com/reports/asia-pacific-phenol-market
https://www.sphericalinsights.com/reports/hepatic-fibrosis-biomarkers-market

 

Conclusion

The ambulatory cardiac monitoring devices market is expected to experience significant growth over the coming decade, driven by the rising prevalence of cardiovascular diseases, increasing aging populations, and rapid technological advancements. The integration of artificial intelligence, wearable ECG monitoring devices, and remote patient monitoring solutions is transforming cardiac care by enabling early detection and continuous heart monitoring outside hospital settings. Strong demand in North America and rapid growth in the Asia-Pacific further highlight the global expansion of this market. Additionally, supportive government initiatives and regulatory approvals are accelerating innovation and adoption. As healthcare shifts toward preventive and home-based care, ambulatory cardiac monitoring devices will play a critical role in improving patient outcomes.

 

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter